• Lifeward appointed Keith D. Rose as chief medical officer to lead global medical strategy as it expands its neurorehabilitation portfolio and advances its Biomed platform.
• Rose previously served as vice president, medical affairs and medical director, neurosciences at the company.
• He brings 30 years of rehabilitation medicine experience, spanning clinical practice, medical technology, and biopharmaceuticals.
• His prior senior roles included medical affairs and clinical leadership positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605190800PRIMZONEFULLFEED9722711) on May 19, 2026, and is solely responsible for the information contained therein.